Skip to main content

renal disease Archives

Analysis seeks to better manage infection in dialysis patients

Apr. 1, 2021—Analysis seeks to better manage infection in dialysis patients

Read more


Implant one day may replace dialysis

May. 18, 2020—Vanderbilt researchers used pharmacological manipulations to increase salt and water transport by kidney cells grown in culture, a step necessary for realizing an implantable artificial kidney device.

Read more


International Society of Nephrology honors Fogo

May. 2, 2019—Agnes Fogo, MD, an internationally known expert in kidney disease at Vanderbilt University Medical Center, has won the 2019 Roscoe Robinson Award from the International Society of Nephrology (ISN).

Read more


Surprising finding in the kidney

Apr. 16, 2015—TGF-beta signaling in the kidney was thought to be a target for reducing renal fibrosis, but Vanderbilt researchers report that fibrosis still occurs in the absence of TGF-beta signaling.

Read more


Study tracks new end-stage renal disease therapy

Aug. 7, 2014—Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more